History
  • No items yet
midpage
315 F. Supp. 3d 143
D.C. Cir.
2018
Read the full case

Background

  • In 2016 the FDA promulgated the "Deeming Rule," bringing cigars, pipe tobacco, e-cigarettes, and related products within the TCA's regulatory scheme, and promulgated a companion "User Fee Rule" assessing user fees on cigar and pipe-tobacco manufacturers/importers.
  • Plaintiffs (three cigar trade associations/retail groups) challenged multiple aspects of both rules; the court limited its review to: health-warning requirements; selective user-fee assessment (excluding e-cigarettes); treating in‑store pipe‑tobacco blenders as "manufacturers" subject to 21 U.S.C. § 387e; and classification of pipes as regulated "components."
  • The Deeming Rule required six rotating textual warnings on cigar packaging (30% of two principal display panels) and advertisements (20% area), larger than prior FTC consent-order warnings; the FDA also deemed "components or parts" (including pipes) but not "accessories."
  • The User Fee Rule required cigar and pipe-tobacco domestic manufacturers/importers to submit data and be assessed fees under a FETRA-derived allocation scheme; FDA declined to assess fees on e-cigarettes, citing statutory limits.
  • Procedurally, parties cross‑moved for partial summary judgment and Plaintiffs sought a preliminary injunction on the warnings; the court consolidated briefing and deferred some claims pending further FDA rulemaking on premium cigars.

Issues

Issue Plaintiff's Argument Defendant's Argument Held
Validity of Deeming Rule health‑warning mandates under TCA/APA FDA failed to make required §387f(d)(1) findings and did not justify departing from FTC warnings; analysis arbitrary FDA made public‑health findings, relied on evidence and international standards, and reasonably adopted larger warnings Upheld: FDA satisfied TCA and APA requirements
First Amendment challenge to warning disclosures Large, prominent warnings "crowd out" commercial speech; prior‑restraint via mandatory rotation plan Warnings are factual, uncontroversial disclosures; Zauderer applies and requirements are reasonable, not unduly burdensome Upheld under Zauderer; prior‑restraint claim not considered (not pleaded)
User Fee Rule: excluding e‑cigarettes from fees Selective assessment is unauthorized, creates unfair "free rider," and is an unconstitutional economic classification Statutory text and cross‑references to FETRA limit fees to enumerated classes (including cigars/pipe tobacco); FDA interpretation reasonable Upheld: statutory scheme compels or permits fee allocation only among listed classes; no tax or Fifth Amendment violation
Treating retail in‑store pipe‑tobacco blenders as "manufacturers" under §387e Retail blenders are not manufacturers; §387e text limits obligations to manufacturers distinct from final sellers FDA treated blending as falling within manufacturer definition and applied §387(20) definitions Vacated & remanded: FDA relied on §387(20) improperly; remand required for reasoned agency determination
Classification of pipes as "components or parts" (vs accessories) "Component" means an integrated ingredient/constituent; pipes are separate vessels, so should be accessories FDA’s definitions reasonably encompass devices (pipes) that alter performance/are used for consumption Upheld: designation as components is permissible and not arbitrary

Key Cases Cited

  • Chevron U.S.A., Inc. v. Natural Resources Defense Council, 467 U.S. 837 (establishing the two‑step framework for judicial review of agency statutory interpretation)
  • Motor Vehicle Manufacturers Ass'n v. State Farm Mutual Automobile Insurance Co., 463 U.S. 29 (agencies must provide reasoned explanations; arbitrary-and-capricious standard)
  • Zauderer v. Office of Disciplinary Counsel, 471 U.S. 626 (lesser First Amendment scrutiny for compelled factual, uncontroversial commercial disclosures)
  • Central Hudson Gas & Electric Corp. v. Public Service Commission, 447 U.S. 557 (intermediate scrutiny test for commercial speech restrictions)
  • RJ Reynolds Tobacco Co. v. FDA, 696 F.3d 1205 (D.C. Cir.) (limits on graphic warnings; discussion of informational vs. anti‑consumption interests)
  • American Meat Institute v. USDA, 760 F.3d 18 (D.C. Cir.) (application of Zauderer to commercial disclosure rules)
  • United States v. Sperry Corp., 493 U.S. 52 (user‑fee characterization and rationality of fee assessments)
  • Lorillard Tobacco Co. v. Reilly, 533 U.S. 525 (regulation of tobacco advertising; government interest in preventing youth tobacco use)
Read the full case

Case Details

Case Name: Cigar Ass'n of Am. v. U.S. Food & Drug Admin.
Court Name: Court of Appeals for the D.C. Circuit
Date Published: May 15, 2018
Citations: 315 F. Supp. 3d 143; Case No. 1:16–cv–01460 (APM)
Docket Number: Case No. 1:16–cv–01460 (APM)
Court Abbreviation: D.C. Cir.
Log In
    Cigar Ass'n of Am. v. U.S. Food & Drug Admin., 315 F. Supp. 3d 143